Monogenic disease genes and hypertension-associated variants identified in GWAS provide important insights into the pathophysiology of hypertension and are potential targets for the development of novel antihypertensive agents
Fernandes Gomes B, Kumar A, Ashton NJ et al (2024) Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders
M., Njengele-Tetyana, Z., Sikhwivhilu, L
doi: 10.3389/fnut.2024.1485632 Received 24 August 2024 Accepted 15 October 2024 Published 24 October 2024 Volume 11 - 2024 Edited by Maria Morgan-Bathke, Viterbo University, United States Reviewed by Eman Mohamad El nashar, King Khalid University, Saudi Arabia Ishraq Alim, Cornell University, United States Updates Copyright 2024 Zhang, Wang, Zhao, He and Sun
Every treatment plan at Vitality Aesthetic & Regenerative Medicine is developed and monitored by experienced professionals who specialize in hormone therapies, peptides, and anti-aging solutions
FMD reduced the number of glial cells and the release of TNF- and IL-1 in PD mice
